Advanced Biomed Common Stock Net Income
| ADVB Stock | 0.32 0.02 5.88% |
As of the 26th of January, Advanced Biomed shows the Mean Deviation of 4.29, standard deviation of 6.51, and Risk Adjusted Performance of (0.02). Advanced Biomed Common technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Advanced Biomed's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Advanced Biomed's valuation are provided below:We have found one hundred twenty available fundamental signals for Advanced Biomed Common, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Advanced Biomed Common prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. | Last Reported | Projected for Next Year | ||
| Net Loss | -2.5 M | -2.6 M | |
| Net Loss | -116.8 K | -122.6 K |
Advanced | Net Income | Build AI portfolio with Advanced Stock |
Latest Advanced Biomed's Net Income Growth Pattern
Below is the plot of the Net Income of Advanced Biomed Common over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Advanced Biomed Common financial statement analysis. It represents the amount of money remaining after all of Advanced Biomed Common operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Advanced Biomed's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Advanced Biomed's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (101.52 K) | 10 Years Trend |
|
Net Income |
| Timeline |
Advanced Net Income Regression Statistics
| Arithmetic Mean | (1,229,466) | |
| Coefficient Of Variation | (68.99) | |
| Mean Deviation | 786,425 | |
| Median | (1,837,158) | |
| Standard Deviation | 848,209 | |
| Sample Variance | 719.5B | |
| Range | 1.7M | |
| R-Value | 0.83 | |
| Mean Square Error | 239B | |
| R-Squared | 0.69 | |
| Significance | 0.000038 | |
| Slope | 139,384 | |
| Total Sum of Squares | 11.5T |
Advanced Net Income History
Other Fundumenentals of Advanced Biomed Common
Advanced Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Advanced Biomed is extremely important. It helps to project a fair market value of Advanced Stock properly, considering its historical fundamentals such as Net Income. Since Advanced Biomed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Advanced Biomed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Advanced Biomed's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Advanced Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Advanced Biomed Common is measured differently than its book value, which is the value of Advanced that is recorded on the company's balance sheet. Investors also form their own opinion of Advanced Biomed's value that differs from its market value or its book value, called intrinsic value, which is Advanced Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Advanced Biomed's market value can be influenced by many factors that don't directly affect Advanced Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Advanced Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Advanced Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Advanced Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Advanced Biomed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Advanced Biomed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Advanced Biomed.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Advanced Biomed on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Advanced Biomed Common or generate 0.0% return on investment in Advanced Biomed over 90 days. Advanced Biomed is related to or competes with BioNexus Gene, Trinity Biotech, Ridgetech, Aptorum Group, Beyond Air, Marker Therapeutics, and Mustang Bio. Advanced Biomed is entity of United States More
Advanced Biomed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Advanced Biomed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Advanced Biomed Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 39.7 | |||
| Value At Risk | (10.81) | |||
| Potential Upside | 13.33 |
Advanced Biomed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Advanced Biomed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Advanced Biomed's standard deviation. In reality, there are many statistical measures that can use Advanced Biomed historical prices to predict the future Advanced Biomed's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (0.13) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Advanced Biomed's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Advanced Biomed January 26, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 4.29 | |||
| Coefficient Of Variation | (2,704) | |||
| Standard Deviation | 6.51 | |||
| Variance | 42.44 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 39.7 | |||
| Value At Risk | (10.81) | |||
| Potential Upside | 13.33 | |||
| Skewness | 0.6509 | |||
| Kurtosis | 2.81 |
Advanced Biomed Common Backtested Returns
Advanced Biomed Common secures Sharpe Ratio (or Efficiency) of -0.0506, which signifies that the company had a -0.0506 % return per unit of risk over the last 3 months. Advanced Biomed Common exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Advanced Biomed's Risk Adjusted Performance of (0.02), standard deviation of 6.51, and Mean Deviation of 4.29 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.89, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Advanced Biomed will likely underperform. At this point, Advanced Biomed Common has a negative expected return of -0.32%. Please make sure to confirm Advanced Biomed's potential upside and the relationship between the accumulation distribution and price action indicator , to decide if Advanced Biomed Common performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.40 |
Average predictability
Advanced Biomed Common has average predictability. Overlapping area represents the amount of predictability between Advanced Biomed time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Advanced Biomed Common price movement. The serial correlation of 0.4 indicates that just about 40.0% of current Advanced Biomed price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.4 | |
| Spearman Rank Test | 0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Advanced Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Advanced Biomed Common reported net income of (101,524). This is 100.03% lower than that of the Health Care Equipment & Supplies sector and 100.06% lower than that of the Health Care industry. The net income for all United States stocks is 100.02% higher than that of the company.
Advanced Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Advanced Biomed's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Advanced Biomed could also be used in its relative valuation, which is a method of valuing Advanced Biomed by comparing valuation metrics of similar companies.Advanced Biomed is currently under evaluation in net income category among its peers.
Advanced Fundamentals
| Return On Equity | -1.65 | ||||
| Return On Asset | -0.35 | ||||
| Current Valuation | 4.28 M | ||||
| Shares Outstanding | 21.64 M | ||||
| Shares Owned By Insiders | 77.53 % | ||||
| Shares Owned By Institutions | 1.21 % | ||||
| Number Of Shares Shorted | 364.42 K | ||||
| Price To Book | 2.30 X | ||||
| EBITDA | (90.81 K) | ||||
| Net Income | (101.52 K) | ||||
| Total Debt | 1.26 M | ||||
| Book Value Per Share | 0.14 X | ||||
| Cash Flow From Operations | (181.46 K) | ||||
| Short Ratio | 0.27 X | ||||
| Earnings Per Share | (0.17) X | ||||
| Number Of Employees | 31 | ||||
| Market Capitalization | 6.91 M | ||||
| Total Asset | 6.51 B | ||||
| Retained Earnings | (19.23 B) | ||||
| Working Capital | 318.65 K | ||||
| Net Asset | 6.51 B |
About Advanced Biomed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Advanced Biomed Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Advanced Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Advanced Biomed Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Advanced Biomed Common offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Advanced Biomed's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Advanced Biomed Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Advanced Biomed Common Stock:Check out Advanced Biomed Piotroski F Score and Advanced Biomed Altman Z Score analysis. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Advanced Biomed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Advanced Biomed Common is measured differently than its book value, which is the value of Advanced that is recorded on the company's balance sheet. Investors also form their own opinion of Advanced Biomed's value that differs from its market value or its book value, called intrinsic value, which is Advanced Biomed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Advanced Biomed's market value can be influenced by many factors that don't directly affect Advanced Biomed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Advanced Biomed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Advanced Biomed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Advanced Biomed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.